Stay updated on Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedNew recruitment status text 'No longer looking for participants' appears on the page, clarifying enrollment status. The page also adds multiple help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label, while the older 'Intervention / Treatment' label and 'Revision: v3.5.5' note were removed in favor of a new 'Revision: v3.6.0' note.SummaryDifference0.3%

- Check16 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a new build deployment. This appears to be a behind-the-scenes update rather than a modification of the trial information.SummaryDifference0.0%

- Check37 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4, indicating deployment of a new build. This is a behind-the-scenes update and does not alter visible content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site/software release rather than any modification to the clinical trial information.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check95 days agoChange DetectedRevision: v3.5.0 released, replacing the previous v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page.